The antiviral therapies remdesivir, molnupiravir, and the active ingredient in Pfizer's Paxlovid pill (nirmatrelvir), remain effective in laboratory tests against the BA.2 variant of SARS-CoV-2, the virus that causes COVID-19.
Mar 10, 2022
0
123
Scientists at Dana-Farber Cancer Institute have developed a drug that potently neutralizes SARS-CoV-2, the COVID-19 coronavirus, and is equally effective against the Omicron variant and every other tested variant. The drug ...
Dec 7, 2022
0
540
In an effort to predict future evolutionary maneuvers of SARS-CoV-2, a research team led by investigators at Harvard Medical School has identified several likely mutations that would allow the virus to evade immune defenses, ...
Dec 2, 2021
3
466
Why are so many vaccinated people getting COVID-19 lately?
Jan 4, 2022
0
22
An Israeli hospital on Monday said preliminary research indicates a fourth dose of the coronavirus vaccine provides only limited defense against the omicron variant that is raging around the world.
Jan 17, 2022
0
275
Biomedical engineers at Duke University have devised a test to quickly and easily assess how well a person's neutralizing antibodies fight infection from multiple variants of COVID-19 such as Delta and the newly discovered ...
Dec 3, 2021
0
261
Scientists at La Jolla Institute for Immunology (LJI) have found that four COVID-19 vaccines (Pfizer-BioNTech, Moderna, J&J/Janssen, and Novavax) prompt the body to make effective, long-lasting T cells against SARS-CoV-2. ...
Jan 24, 2022
0
524
Researchers at Karolinska Institutet and Danderyd Hospital have followed recipients of the new updated COVID-19 vaccine and analyzed the antibody response to different SARS-CoV-2 variants. The results show a surprisingly ...
Dec 22, 2023
0
116
In a recent study, researchers from Karolinska Institutet and others have characterized the new omicron variant BA.2.75, comparing its ability to evade antibodies against current and previous variants. The study, published ...
Sep 2, 2022
0
56
BA.4.6, a subvariant of the omicron COVID variant which has been quickly gaining traction in the U.S., is now confirmed to be spreading in the U.K.
Sep 14, 2022
0
24
